Showing results (41-50 of 216) with videos related to
Sort By:
Pageof 22
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cellsHans J J van der Vliet, Ruojie Wang, Simon C Yue, et al.Frontiers in Immunology|June 17, 2017
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future DevelopmentsJohn P Veluchamy, Nina Kok, Hans J van der Vliet, et al.Injury|September 22, 2018
Functional outcomes of traumatic midfoot injuriesQuirine M J van der Vliet, Thirza A Esselink, Marilyn Heng, et al.British Journal of Pharmacology|March 5, 2011
Central activation of the cholinergic anti-inflammatory pathway reduces surgical inflammation in experimental post-operative ileusFo The, C Cailotto, J van der Vliet, et al.Oncoimmunology|May 6, 2015
Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapyInge M Werter, Famke L Schneiders, Emmanuel Scotet, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 18, 2019
Routine incorporation of longer-term patient-reported outcomes into a Dutch trauma registryQuirine M J van der Vliet, Abhiram R Bhashyam, Falco Hietbrink, et al.Case Reports in Oncology|March 2, 2012
Irinotecan-induced dysarthriaAlbertine J Dressel, Johannes C van der Mijn, Ijke J Aalders, et al.Human Immunology|March 15, 2000
Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitroN Nishi, H J van der Vliet, Y Koezuka, et al.Injury|February 13, 2018
Epidemiology of distal radius fractures in polytrauma patients and the influence of high traumatic energy transferSteven Ferree, Quirine M J van der Vliet, Femke Nawijn, et al.Journal for Immunotherapy of Cancer|October 29, 2025
PD-L1 directed bispecific Vδ2-T cell engager combines lysis of PD-L1 expressing tumor cells with PD-1 immune checkpoint inhibition and modulation of the tumor immune microenvironmentLisa A King, Myrthe Veth, Marieke Roos, et al.Pageof 22